UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Quantitative Analysis for Chinese and US-listed Pharmaceutical Companies by the LightGBM Algorithm Journal article
Zheng,Wenwen, Junjun Li,, Wang,Yu, Ye,Zhuyifan, Zhong,Hao, Kot,Hung Wan, Ouyang,Defang, Chan,Ging. Quantitative Analysis for Chinese and US-listed Pharmaceutical Companies by the LightGBM Algorithm[J]. Current Computer-Aided Drug Design, 2023, 19(6), 405-415.
Authors:  Zheng,Wenwen;  Junjun Li,;  Wang,Yu;  Ye,Zhuyifan;  Zhong,Hao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:1.5/1.5 | Submit date:2023/08/03
Algorithm  Lightgbm  Machine Learning  Pharmaceutical Industry  Quantitative Analysis  r&d  
The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018 Journal article
Hao Zhong, Defang Ouyang. The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018[J]. Scientometrics, 2020, 122(2), 1113-1128.
Authors:  Hao Zhong;  Defang Ouyang
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:3.5/3.8 | Submit date:2021/03/02
Chinese Pharmaceutical Academia  Gap Analysis  Pharmaceutical Industry  Pharmaceutics  r&d Capacity  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
Kong, Xiangjun, Wan, Jian-bo, Hu, Hao, Su, Shibing, Hu, Yuanjia. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies[J]. MABS, 2017, 9(7), 1041-1051.
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite | TC[WOS]:5 TC[Scopus]:9  IF:5.6/5.8 | Submit date:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
Kong, Xiangjun, Wan, Jian-bo, Hu, Hao, Su, Shibing, Hu, Yuanjia. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies[J]. MABS, 2017, 9(7), 1041-1051.
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite | TC[WOS]:5 TC[Scopus]:9  IF:5.6/5.8 | Submit date:2020/05/08
Pharmaceutical Companies  Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Technological Innovation  
R&D internationalisation patterns in the global pharmaceutical industry: evidence from a network analytic perspective Journal article
Hu Y., Scherngell T., Qiu L., Wang Y.. R&D internationalisation patterns in the global pharmaceutical industry: evidence from a network analytic perspective[J]. Technology Analysis and Strategic Management, 2015, 27(5), 532.
Authors:  Hu Y.;  Scherngell T.;  Qiu L.;  Wang Y.
Favorite | TC[WOS]:18 TC[Scopus]:20 | Submit date:2018/10/31
Pharmaceutical Industry  r&d Networks  Social Network Analysis  
Contract research organizations (CROs) in China: Integrating Chinese research and development capabilities for global drug innovation Journal article
Shi Y.-Z., Hu H., Wang C.. Contract research organizations (CROs) in China: Integrating Chinese research and development capabilities for global drug innovation[J]. Globalization and Health, 2014, 10(1).
Authors:  Shi Y.-Z.;  Hu H.;  Wang C.
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date:2018/11/07
China  Contract Research Organization  Cro  Global Integration  Pharmaceutical r & d  
Using Complex Products and Systems in the Pharmaceutical Innovation: Case study of R&D project in pharmaceutical industry Conference paper
Lu Z., Hu H.. Using Complex Products and Systems in the Pharmaceutical Innovation: Case study of R&D project in pharmaceutical industry[C], 2011, 83-87.
Authors:  Lu Z.;  Hu H.
Favorite | TC[Scopus]:0 | Submit date:2018/12/28
case study  Complex Products and Systems (CoPS)  complexity  pharmaceutical R&D project  
中国研发导向型制药企业外部资源整合行为探究 Journal article
Yu, WX, Hu, H., Shi, LW, Wang, YT. 中国研发导向型制药企业外部资源整合行为探究[J]. 科技進步與對策, 2011, 85-89.
Authors:  Yu, WX;  Hu, H.;  Shi, LW;  Wang, YT
Favorite |  | Submit date:2022/07/27
marketing  R&D  pharmaceutical